{"nctId":"NCT00511810","briefTitle":"Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder","startDateStruct":{"date":"2007-08"},"conditions":["Major Depressive Disorder"],"count":20,"armGroups":[{"label":"Low Dose Fish Oil","type":"EXPERIMENTAL","interventionNames":["Drug: Low Dose Fish Oil"]},{"label":"High Dose Fish Oil","type":"EXPERIMENTAL","interventionNames":["Drug: High Dose Fish Oil"]}],"interventions":[{"name":"Low Dose Fish Oil","otherNames":["OmegaRx - Zone Laboratories"]},{"name":"High Dose Fish Oil","otherNames":["OmegaRx - Zone Laboratories"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criterion:\n\n* Between the ages of 12-18 years.\n* Diagnosis of MDD and not exhibited symptom remission CDRS-R (\\> 28 but \\< 40) despite being administered a standard therapeutic dose of an SSRI continuously for a minimum of 6 weeks.\n* Ability and willingness to provide assent and informed, written consent from at least one biological parent.\n* Present with biological parent or legal guardian.\n* Willingness to maintain current dietary habits.\n* Permission from treating physician\n* Able to perform fMRI/MRS.\n\nExclusion Criterion:\n\n* Inability or unwillingness to provide consent.\n* Antecedent or concurrent serious medical illness.\n* Clinically unstable medical disease, including cardiovascular, hepatic insufficiency, severe renal impairment, gastrointestinal, pulmonary, metabolic, endocrine, obesity or other systemic disease.\n* History of seizures, excluding febrile seizures in childhood.\n* Patients requiring treatment with any drug which might obscure the action of the study treatment.\n* Female patients who are either pregnant or lactating.\n* Clinically significant laboratory abnormalities in the last year on CBC or TSH tests.\n* Judged clinically to be at suicidal risk (defined as having active suicidal ideation, intent or plan, or a serious suicide attempt within the past 6 months, or a baseline CDRS-R suicide score of \\>3).\n* Hospitalized within the last 3 months\n* Greater than 1 year outside appropriate age/grade level\n* Pacemaker\n* Cerebral aneurysm clip\n* Cochlear implant\n* Metal fragments lodged within the eye or braces\n* Claustrophobia\n* Necessity of sedation (no sedation will be given).\n* History of loss of consciousness \\> 10 minutes in duration\n* Allergy to seafood.","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Years","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mood Symptoms Ratings","description":"Depression symptom severity was determined with the Children's Depression Rating Scale-Revised (CDRS-R), which is a brief rating scale based on a semi-structured interview with the child. It is a 17-item observer-rated questionnaire where the 17 symptom areas are rated on a 6- or 7-point scale. Total score ranges from a low (not depressed) of 17 to a maximum (very depressed) of 108. Remission was defined as a CDRS-R score of \\<28. (The total score is the sum of the ratings on each of the 17 items.)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"33.0","spread":"1.5"},{"groupId":"OG001","value":"33.1","spread":"1.7"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":8},"commonTop":[]}}}